Tokenization May Enable Investors to Shop for Yield Michael Saylor Suggests Posing Challenge to Traditional Finance Elevation Capital Offloads Rs 964 Crore in Paytm Shares via Block Deals Tech Media Telecom Roundup Market Talk Highlights DeepSeek SoFi and Sector Trends Gold and Silver Futures Extend Weakness as Breakdown Risk Persists Ajmera Realty Shares Surge Nearly 10 on Strong FY26 Results Sets Ambitious FY27 PreSales Target International Aid Sector Faces Pressure to Overhaul Outdated Models Amid Budget Cuts EPAC Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher SHW Q1 2026 Earnings EPS Surpasses Estimates on Solid Execution SEE Q4 2025 Earnings Earnings Beat Driven by Operational Discipline Revenue Details Unavailable Advantage Solutions Inc ADV Q1 2026 Earnings EPS Surges 629 Above Estimates Stock Climbs BBDC Q1 2026 Earnings EPS Falls Short as Stock Rises Affiliated Managers Group Inc AMG Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Vita Coco COCO Holds Near Resistance Amid LowVolume Consolidation Prosperity Bancshares PB Slips 133 as Support Test Looms Sector Headwinds Persist Western Asset InflationLinked Opportunities Income Fund WIW Inches Higher as Investors Eye Inflation Data Rezolute Inc RZLT Pushes Higher on Modest Volume as Traders Eye Biotech Catalysts ConnectOne Bancorp CNOB Slips 117 as Resistance Caps NearTerm Gains Apple Incs Durable Growth Narrative Strengthens Amid Services Expansion and Ecosystem Loyalty HSIC Q1 2026 Earnings Strong EPS Beat Amid Solid Operational Performance Fennec Pharmaceuticals FENC Gains 17 as Shares Bounce Off Support Key Levels in Focus Crane Harbor Acquisition Corp II Rights CRANR Holds Steady at 022 as Market Awaits Catalysts Pacific Biosciences PACB Surges 1395 Momentum Building Above Key Support CocaCola Consolidated COKE Faces Resistance as Shares Pull Back 223 Ethan Allen Interiors ETD Holds Near Support as Modest Gains Signal Stability Docebo DCBO Slips Testing Key Support Levels Amid Market Headwinds RQI Edges Higher Amid Real Estate Sector Stability Myriad Genetics MYGN Slips as Stock Navigates Support Levels Near 359